Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05190874 · ClinicalTrials.gov registry record

Grappler Interference Screw Post-Market Collection of Patient Reported Outcome Measures

A clinical trial, sponsored by Paragon 28.

Completed
Registry status
19
Enrollment target

NCT05190874: Completed study, sponsored by Paragon 28.

NCT05190874 is a clinical trial that has completed, run by Paragon 28. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05190874 has completed, sponsored by Paragon 28.

COMPLETED
Registry status
19 participants
Enrollment target

Study Summary

Ambispective, multi-surgeon, single site, consecutive case series to determine the safety, performance, and benefits of the Grappler(R) Interference Screw.

Primary Outcome

Device performance and benefits as related to Foot and Ankle Mobility Measure Activities of Daily Living (0-84) and sports (0-32) subscales. The higher the score, the higher the level of function, with 100% representing no dysfunction.

Interventions

  • DEVICE Grappler Interference Screw System

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2022-01-14
Est. Completion 2022-04-06
Paragon 28

7 total trials

What the finished NCT05190874 record still lists

NCT05190874 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 19 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Grappler Interference Screw System is the first listed.

NCT05190874 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05190874 about?

NCT05190874 is a clinical study titled "Grappler Interference Screw Post-Market Collection of Patient Reported Outcome Measures". Ambispective, multi-surgeon, single site, consecutive case series to determine the safety, performance, and benefits of the Grappler(R) Interference Screw.

What is the current status of trial NCT05190874?

This trial is currently completed. The enrollment target is 19 participants. The study started on 2022-01-14. Estimated completion is 2022-04-06.

What interventions are being tested in trial NCT05190874?

The interventions under investigation include: Grappler Interference Screw System (DEVICE).

Who is sponsoring clinical trial NCT05190874?

This trial is sponsored by Paragon 28, which has 7 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03207464 · 19 participants · Phase 1

    Molecular Imaging of NET Using [C-11]MRB-PET in MS

  • NCT04318717 · 19 participants · Phase 2

    Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

  • NCT05103904 · 19 participants · Phase 2

    Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

  • NCT05607407 · 19 participants · Phase 2

    Methimazole in Patients With Progressive Glioblastoma

Similar registry start date

  • NCT05043051 · started 2022-01-14 · NA

    Autoimmune Basis for Postural Tachycardia Syndrome

  • NCT05067634 · started 2022-01-14 · Phase 3

    Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures

  • NCT05139017 · started 2022-01-14 · Phase 2

    A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)

  • NCT05188508 · started 2022-01-14 · Phase 2

    Pembrolizumab, Olaparib, and Temozolomide for People With Glioma

Source: ClinicalTrials.gov NCT05190874, the US trial registry maintained by the National Library of Medicine. NCT05190874 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.